ICARISIDE II
公式表示名・定義
JCIA 표시명 イカリシドⅡ: 本品は、次の化学式で表される有機化合物である。
別名・識別情報
ICARISIDE IIINCIICARISIDE II동의어
- cas
- 113558-15-9
- dtxsid
- DTXSID40150457
- dtxcid
- DTXCID4072948
- IUPAC
- 5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4-oxo-4H-1-benzopyran-3-yl 6-deoxy-alpha-L-mannopyranoside
- 분자식
- C27H30O10
- 분자량
- 514.527 g/mol
化粧品での役割
BLEACHINGSKIN CONDITIONING - EMOLLIENTSKIN PROTECTINGSKIN CONDITIONINGANTIOXIDANT
安全性・規制情報
Other restriction: ban substances that deplete the ozone layer
連携済み公式原本データ
関連文献
- Xianling Lianxia formula enhances the inhibitory effects of trastuzumab on HER2-positive breast cancer · 2023
- Epimedium brevicornum Maxim. Extract exhibits pigmentation by melanin biosynthesis and melanosome biogenesis/transfer · 2022
- Icariside II overcomes BRAF inhibitor resistance in melanoma by inducing ROS production and inhibiting MITF. · 2020
- Blockade of epidermal growth factor receptor/mammalian target of rapamycin pathway by Icariside II results in reduced cell proliferation of osteosarcoma cells. · 2014
- Icariside II induces apoptosis via inhibition of the EGFR pathways in A431 human epidermoid carcinoma cells. · 2013